Abstract:Clinical evidence of hematopoietic restoration with umbilical cord blood (UCB) grafts indicates the UCB can be a useful source of hematopoietic stem cells for routine bone marrow reconstitution. Considering (10 +/- 5) x 10(8) nucleared cells per cord blood unit, there is a potential limitation for the use of cord blood in adults, which, however, can be overcome by ex vivo expansion of cells. A prerequisite for expansion is the significantly higher recovery of MNC, CD34+ cells and colony-forming cells (CFC) by thawing cryopreserved MNC. Cooling rate always acts as a critical factor that can affect the recovery of cells. Although the rate of - 1 degrees C/min is adopted in most of the cryopreservations, no data has been reported about the detailed effects of different cooling rates. The aim of the study was to reveal the different effects of cooling rates on cryopreservation of hematopoietic stem cells from cord blood. UCB samples were collected, and cryopreserved as mononuclear cells (MNC) with different cooling rates of - 0.5 degrees C/min, - 1 degrees C/min, - 5 degrees C/min, and the recovery and viability of MNC and CD34+ cells, the clonogenic capacity and the ex vivo expansion potential of UCB progenitor cells were evaluated after thawing. With - 1 degrees C/min cooling rate, the recovery of MNC reached 93.3% +/- 1.8% , viability 95.0% +/- 3.9% , recovery of CD34+ cells 80.0% +/- 17.9% , and clonogenic recovery were 87.1% +/- 5.5%, 88.5% +/- 8.9%, 86.2% +/- 7.4% for BFU-E CFU-GM CFU-MK, respectively. After 14 days of liquid culture, no significant difference was detected in CFC expansion between fresh and cryopreserved MNC cells with - 1 degrees C/min cooling rate, but this was not the case with - 0.5 degreesC/min and - 5 degrees C/min. In conclusion, it was demonstrated that controlling the rate at - 1 degrees C/min is more suitable for cryopreservation of hematopoietic stem cells than - 0.5 degrees C/min and - 5 degrees C/min.

Umbilical cord blood cryopreservation by vitrification method

Study on Cryopreservation of Human Cord Blood Stem Cell

Preliminary Study on the Freeze-Drying of Human Bone Marrow-Derived Mesenchymal Stem Cells

Cryopreservation of umbilical cord blood-derived mesenchymal stem cells without dimethyl sulfoxide

Comparative study on effects of cryopreservation of umbilical cord hematopoietic stem/progenitor cells

Quality of umbilical cord blood CD34+ cells in a double-compartment freezing bag cryopreserved without a rate-controlled programmed freezer

[Study on Non-Programmed Process Using Dimethyl Sulfoxide and Hydroxyethyl Starch As Cryoprotectants in Cryopreservation of Cord Blood Hematopoietic Cells].

Comparison of the Effects of Different Cryoprotectants on Stem Cells from Umbilical Cord Blood

Vitreous Cryopreservation of Human Umbilical Vein Endothelial Cells with Low Concentration of Cryoprotective Agents for Vascular Tissue Engineering.

Dimethyl Sulfoxide-Free Cryopreservation of Human Umbilical Cord Mesenchymal Stem Cells Based on Zwitterionic Betaine and Electroporation

Optimal Length of Time of Cryopreserved Umbilical Cord Blood Infusion after Thawing.

[Effect of Different Cryopreservation Time on Quality of Umbilical Cord Blood Cells].

The First Attempt at Vitrification of Biopsied Human Cleavage Stage Embryos

[Effects of Different Cooling Rates on Cryopreservation of Hematopoietic Stem Cells from Cord Blood].

Experimental Study of Vitrification Preservation for BMSCs

Quality evaluation of umbilical cord blood progenitor cells cryopreserved with a small-scale automated liquid nitrogen system

Study of the biological characteristics of human umbilical cord mesenchymal stem cells after long-time cryopreservation

Vitrification for cryopreservation of 2D and 3D stem cells culture using high concentration of cryoprotective agents

Effects of cryopreservation on the neural differentation potential of human umbilical cord mesenchymal stem cells

Microencapsulation Facilitates Low-Cryoprotectant Vitrification of Human Umbilical Vein Endothelial Cells

Osteogenic differentiation of GFP-labeled human umbilical cord blood derived mesenchymal stem cells after cryopreservation.